サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514925

破傷風トキソイドワクチン市場：タイプ別、形態別、流通別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Tetanus Toxoid Vaccine Market, By Type, By Form, By Distribution, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 387 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.90円
破傷風トキソイドワクチン市場：タイプ別、形態別、流通別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年06月11日
発行: AnalystView Market Insights
ページ情報: 英文 387 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

破傷風トキソイドワクチン市場規模は2023年に49億8,678万米ドルとなり、2024年から2032年にかけてCAGR 5.9%で拡大

破傷風トキソイドワクチン市場- 市場力学

破傷風トキソイドワクチンの認知度向上と政府の取り組みが市場成長を牽引

破傷風トキソイドワクチン市場は、世界の認知度の向上と政府の取り組みに後押しされ、大きな成長を遂げています。例えば、世界保健機関（WHO）や米国疾病予防管理センター（CDC）などの組織は、予防接種プログラムの重要な要素として破傷風ワクチン接種を積極的に推進しており、国民の意識向上に貢献しています。さらに、インドやナイジェリアなどの政府は、破傷風と効果的に闘うために、社会的弱者や農村部を対象とした包括的なワクチン接種キャンペーンを実施しています。ユニセフのデータによると、出生時の乳幼児に対する破傷風トキソイドワクチンの世界の接種率は、2000年の74%から2020年には86%に増加しており、これはワクチン接種率を拡大するための協調的努力の影響を反映しています。これらのイニシアチブは、破傷風トキソイドワクチン市場の成長を促進する上で、意識の向上と政府の支援が極めて重要な役割を果たすことを強調しています。

破傷風トキソイドワクチン市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約5.9％のCAGRで毎年成長すると推定されています。

タイプ別では、混合ワクチンが2023年に最大の市場シェアを示すと予測されています。

形態別では、2023年に凍結乾燥ワクチンが主要なタイプでした。

流通セグメント別では、2023年には病院薬局が主要タイプとなっています。

地域別では、北米が2023年に収益でリードしました。

破傷風トキソイドワクチン市場-セグメンテーション分析：

破傷風トキソイドワクチンの世界市場は、タイプ、形態、流通、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプによって2つに分類される：一価破傷風トキソイドワクチンと混合ワクチンです。混合ワクチンは、1つの製剤で複数の疾病を予防することができ、利便性が高いです。一価破傷風トキソイドワクチンがこれに続き、破傷風感染に対する標的免疫で特定のワクチン接種ニーズに対応しています。

市場は剤形によって2つのカテゴリーに分けられる：液体ワクチンと凍結乾燥ワクチンです。凍結乾燥ワクチンは、液体製剤に比べて安定性が高く、保存期間が長いため、主流となっています。液体ワクチンがこれに続き、投与の利便性を提供するが、有効性を維持するためには慎重な保管と取り扱いが必要です。

破傷風トキソイドワクチン市場-地理的洞察

米国や欧州諸国など、ヘルスケアインフラが整備された先進諸国では、予防接種プログラムが確立されており、規制の枠組みも厳しいため、ワクチン接種率が高いです。一方、アジア太平洋やアフリカの新興国は、ワクチンの入手や保管、流通インフラに関する課題に直面しており、ワクチン接種率に影響を与えています。しかし、政府のイニシアティブや国際機関との協力により、これらの地域ではワクチンへのアクセスや接種率を向上させる取り組みが推進されています。さらに、東南アジアやサハラ以南のアフリカなど、自然災害や人道的危機に見舞われやすい地域では、脆弱な人々の間で破傷風が発生するのを防ぐため、しばしば標的を絞ったワクチン接種キャンペーンが行われています。

破傷風トキソイドワクチン市場-競合情勢：

破傷風トキソイドワクチン市場の競合情勢は、GSK、Sanofi Pasteur、Merck &Co., Inc.などの主要企業が、広範なワクチンポートフォリオと世界な展開で市場を独占していることが特徴です。これらの企業は、強力な研究開発能力、規制に関する専門知識、製造能力を活用し、市場でのリーダーシップを維持しています。さらに、政府機関、国際機関、非営利団体との戦略的提携により、市場での存在感を高め、世界中のワクチン接種プログラムへのアクセスを容易にしています。さらに、新興企業や地域のワクチンメーカーは、特定の地域に合わせた費用対効果の高い代替品やニッチなワクチン製剤を提供することで、市場競争に貢献しています。ワクチンの生産と流通における技術的進歩は、ワクチン開拓への投資の増加とともに破傷風トキソイドワクチン市場の競争をさらに激化させています。

目次

第1章 破傷風トキソイドワクチン市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 破傷風トキソイドワクチンの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 破傷風トキソイドワクチン産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 破傷風トキソイドワクチン市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 破傷風トキソイドワクチン市場情勢

  • 破傷風トキソイドワクチン市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 破傷風トキソイドワクチン市場：タイプ別

  • 概要
    • セグメントシェア分析
    • 一価破傷風トキソイドワクチン
    • 混合ワクチン

第8章 破傷風トキソイドワクチン市場：形態別

  • 概要
    • セグメントシェア分析
    • 液体
    • 凍結乾燥

第9章 破傷風トキソイドワクチン市場：流通別

  • 概要
    • セグメントシェア分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局
    • 政府サプライヤー

第10章 破傷風トキソイドワクチン市場：エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 病院
    • クリニック
    • 公衆衛生機関
    • 在宅ケア環境

第11章 破傷風トキソイドワクチン市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 破傷風トキソイドワクチン業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Astellas Pharma Inc.
    • Bharat Biotech International Limited
    • Biological E. Limited
    • China National Pharmaceutical Group Corporation
    • Emergent BioSolutions Inc.
    • GlaxoSmithKline Biologicals SA
    • Indian Immunologicals Limited
    • Lupin Limited
    • Merck Sharp &Dohme Corp.
    • Mitsubishi Tanabe Pharma Corporation
    • Novartis Vaccines and Diagnostics, Inc.
    • Panacea Biotec Limited
    • Pfizer Inc.
    • Sanofi Pasteur Inc.
    • Serum Institute of India Pvt. Ltd.
    • Shenzhen Kangtai Biological Products Co., Ltd.
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Tetanus Toxoid Vaccine Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Tetanus Toxoid Vaccine Market, by Type 2019-2032 (USD Million)
  • TABLE Tetanus Toxoid Vaccine Market: Form Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Form
  • TABLE Global Tetanus Toxoid Vaccine Market, by Form 2019-2032 (USD Million)
  • TABLE Tetanus Toxoid Vaccine Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Tetanus Toxoid Vaccine Market, by Distribution 2019-2032 (USD Million)
  • TABLE Tetanus Toxoid Vaccine Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Tetanus Toxoid Vaccine Market, by End-User 2019-2032 (USD Million)
  • TABLE Tetanus Toxoid Vaccine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Tetanus Toxoid Vaccine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Tetanus Toxoid Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Tetanus Toxoid Vaccine Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Tetanus Toxoid Vaccine Market, by Form, 2019-2032 (USD Million)
  • TABLE North America Tetanus Toxoid Vaccine Market, by Distribution, 2019-2032 (USD Million)
  • TABLE North America Tetanus Toxoid Vaccine Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Tetanus Toxoid Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Tetanus Toxoid Vaccine Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Tetanus Toxoid Vaccine Market, by Form, 2019-2032 (USD Million)
  • TABLE Europe Tetanus Toxoid Vaccine Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Europe Tetanus Toxoid Vaccine Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tetanus Toxoid Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tetanus Toxoid Vaccine Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tetanus Toxoid Vaccine Market, by Form, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tetanus Toxoid Vaccine Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tetanus Toxoid Vaccine Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Tetanus Toxoid Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Tetanus Toxoid Vaccine Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Tetanus Toxoid Vaccine Market, by Form, 2019-2032 (USD Million)
  • TABLE Latin America Tetanus Toxoid Vaccine Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Latin America Tetanus Toxoid Vaccine Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tetanus Toxoid Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tetanus Toxoid Vaccine Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tetanus Toxoid Vaccine Market, by Form, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tetanus Toxoid Vaccine Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tetanus Toxoid Vaccine Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Tetanus Toxoid Vaccine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Form segment market share analysis, 2023 & 2032
  • FIGURE Form segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution segment market share analysis, 2023 & 2032
  • FIGURE Distribution segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Tetanus Toxoid Vaccine Market share and leading players, 2023
  • FIGURE Europe Tetanus Toxoid Vaccine Market share and leading players, 2023
  • FIGURE Asia Pacific Tetanus Toxoid Vaccine Market share and leading players, 2023
  • FIGURE Latin America Tetanus Toxoid Vaccine Market share and leading players, 2023
  • FIGURE Middle East and Africa Tetanus Toxoid Vaccine Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Tetanus Toxoid Vaccine Market share analysis by country, 2023
  • FIGURE Germany Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Tetanus Toxoid Vaccine Market share analysis by country, 2023
  • FIGURE India Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Tetanus Toxoid Vaccine Market share analysis by country, 2023
  • FIGURE Brazil Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Tetanus Toxoid Vaccine Market share analysis by country, 2023
  • FIGURE Saudi Arabia Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Tetanus Toxoid Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2996

REPORT HIGHLIGHT

The Tetanus Toxoid Vaccine Market size was valued at USD 4,986.78 million in 2023, expanding at a CAGR of 5.9% from 2024 to 2032.

The Tetanus Toxoid Vaccine Market involves the production and distribution of vaccines designed to provide immunity against tetanus, a potentially deadly bacterial infection. The continued focus on immunization programs worldwide, growing awareness about the importance of vaccination, and the inclusion of tetanus toxoid vaccines in routine immunization schedules are driving the market growth. However, restraints include challenges related to vaccine storage and distribution in remote or low-resource settings, as well as concerns about vaccine safety and efficacy. Market opportunities lie in expanding access to vaccination in emerging economies, advancements in vaccine technology to improve storage stability, and the development of combination vaccines for broader protection against multiple diseases.

Tetanus Toxoid Vaccine Market- Market Dynamics

Rising Awareness and Government Initiatives Drive Tetanus Toxoid Vaccine Market Growth

The Tetanus Toxoid Vaccine Market is experiencing significant growth propelled by increasing awareness and government initiatives worldwide. For example, organizations like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) actively promote tetanus vaccination as a crucial component of immunization programs, contributing to heightened public awareness. Furthermore, governments in countries such as India and Nigeria have implemented comprehensive vaccination campaigns, targeting vulnerable populations and rural areas to combat tetanus effectively. According to data from UNICEF, global coverage of tetanus toxoid vaccination for infants at birth increased from 74% in 2000 to 86% in 2020, reflecting the impact of concerted efforts to expand vaccination coverage. These initiatives underscore the pivotal role of raising awareness and government support in driving the growth of the Tetanus Toxoid Vaccine Market.

Tetanus Toxoid Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.9% over the forecast period (2024-2032)

Based on Type segmentation, Combination Vaccines were predicted to show maximum market share in the year 2023

Based on Form segmentation, Lyophilized was the leading type in 2023

Based on distribution segmentation, Hospital Pharmacies was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Tetanus Toxoid Vaccine Market- Segmentation Analysis:

The Global Tetanus Toxoid Vaccine Market is segmented based on Type, Form, Distribution, End-User, and Region.

The market is divided into two categories based on Type: Monovalent Tetanus Toxoid Vaccines and Combination Vaccines. Combination vaccines as the dominant segment, offering convenience and broader protection against multiple diseases in a single formulation. Monovalent tetanus toxoid vaccines follow, serving specific vaccination needs with targeted immunization against tetanus infection.

The market is divided into two categories based on Form: Liquid and Lyophilized. Lyophilized vaccines are the predominant segment, offering enhanced stability and longer shelf life compared to liquid formulations. Liquid vaccines follow, providing convenience in administration but requiring careful storage and handling to maintain efficacy.

Tetanus Toxoid Vaccine Market- Geographical Insights

Developed countries with robust healthcare infrastructures, such as the United States and European nations, exhibit high vaccination coverage rates due to well-established immunization programs and stringent regulatory frameworks. In contrast, emerging economies in Asia-Pacific and Africa face challenges related to vaccine accessibility, storage, and distribution infrastructure, impacting vaccination coverage rates. However, government initiatives and collaborations with international organizations are driving efforts to improve vaccine access and coverage in these regions. Moreover, regions prone to natural disasters or humanitarian crises, such as Southeast Asia and Sub-Saharan Africa, often witness targeted vaccination campaigns to prevent tetanus outbreaks among vulnerable populations.

Tetanus Toxoid Vaccine Market- Competitive Landscape:

The competitive landscape of the Tetanus Toxoid Vaccine Market is characterized by the presence of key players such as GSK, Sanofi Pasteur, and Merck & Co., Inc., dominating the market with their extensive vaccine portfolios and global reach. These companies leverage their strong research and development capabilities, regulatory expertise, and manufacturing capacities to maintain their market leadership. Additionally, strategic collaborations with government agencies, international organizations, and non-profit entities bolster their market presence and facilitate access to vaccination programs worldwide. Moreover, emerging players and regional vaccine manufacturers contribute to market competition by offering cost-effective alternatives and niche vaccine formulations tailored to specific geographical regions. Technological advancements in vaccine production and distribution, along with increasing investments in vaccine development, further intensify competition in the Tetanus Toxoid Vaccine Market.

Recent Developments:

In August 2022, IBSS Biomed S.A. initiated a clinical trial to evaluate the efficacy and safety of CLODIVAC, it's bivalent tetanus and diphtheria vaccine, as a booster immunization alongside Sanofi Pasteur's Td-Impfstoff Merieux, targeting healthy adults.

In August 2022, Madhya Pradesh, India's Public Health and Family Welfare Minister inaugurated the state-level DPT/TD vaccination campaign at the Kamala Nehru Girls School Auditorium in Bhopal, aiming to promote immunization against diphtheria, pertussis, and tetanus.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TETANUS TOXOID VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Astellas Pharma Inc.

Bharat Biotech International Limited

Biological E. Limited

China National Pharmaceutical Group Corporation

Emergent BioSolutions Inc.

GlaxoSmithKline Biologicals S.A.

Indian Immunologicals Limited

Lupin Limited

Merck Sharp & Dohme Corp.

Mitsubishi Tanabe Pharma Corporation

Novartis Vaccines and Diagnostics, Inc.

Panacea Biotec Limited

Pfizer Inc.

Sanofi Pasteur Inc.

Serum Institute of India Pvt. Ltd.

Shenzhen Kangtai Biological Products Co., Ltd.

Others

GLOBAL TETANUS TOXOID VACCINE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Monovalent Tetanus Toxoid Vaccine
  • Combination Vaccines

GLOBAL TETANUS TOXOID VACCINE MARKET, BY FORM- MARKET ANALYSIS, 2019 - 2032

  • Liquid
  • Lyophilized

GLOBAL TETANUS TOXOID VACCINE MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Government Suppliers

GLOBAL TETANUS TOXOID VACCINE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Public Health Agencies
  • Homecare Settings

GLOBAL TETANUS TOXOID VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Tetanus Toxoid Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Tetanus Toxoid Vaccine Market Snippet by Type
    • 2.1.2. Tetanus Toxoid Vaccine Market Snippet by Form
    • 2.1.3. Tetanus Toxoid Vaccine Market Snippet by Distribution
    • 2.1.4. Tetanus Toxoid Vaccine Market Snippet by End-User
    • 2.1.5. Tetanus Toxoid Vaccine Market Snippet by Country
    • 2.1.6. Tetanus Toxoid Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Tetanus Toxoid Vaccine Key Market Trends

  • 3.1. Tetanus Toxoid Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Tetanus Toxoid Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Tetanus Toxoid Vaccine Market Opportunities
  • 3.4. Tetanus Toxoid Vaccine Market Future Trends

4. Tetanus Toxoid Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Tetanus Toxoid Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Tetanus Toxoid Vaccine Market Landscape

  • 6.1. Tetanus Toxoid Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Tetanus Toxoid Vaccine Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Monovalent Tetanus Toxoid Vaccine
    • 7.1.3. Combination Vaccines

8. Tetanus Toxoid Vaccine Market - By Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Form, 2023 & 2032 (%)
    • 8.1.2. Liquid
    • 8.1.3. Lyophilized

9. Tetanus Toxoid Vaccine Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies
    • 9.1.5. Government Suppliers

10. Tetanus Toxoid Vaccine Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Public Health Agencies
    • 10.1.5. Homecare Settings

11. Tetanus Toxoid Vaccine Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Tetanus Toxoid Vaccine Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Tetanus Toxoid Vaccine Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Tetanus Toxoid Vaccine Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Tetanus Toxoid Vaccine Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Tetanus Toxoid Vaccine Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Tetanus Toxoid Vaccine Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Astellas Pharma Inc.
    • 12.2.2. Bharat Biotech International Limited
    • 12.2.3. Biological E. Limited
    • 12.2.4. China National Pharmaceutical Group Corporation
    • 12.2.5. Emergent BioSolutions Inc.
    • 12.2.6. GlaxoSmithKline Biologicals S.A.
    • 12.2.7. Indian Immunologicals Limited
    • 12.2.8. Lupin Limited
    • 12.2.9. Merck Sharp & Dohme Corp.
    • 12.2.10. Mitsubishi Tanabe Pharma Corporation
    • 12.2.11. Novartis Vaccines and Diagnostics, Inc.
    • 12.2.12. Panacea Biotec Limited
    • 12.2.13. Pfizer Inc.
    • 12.2.14. Sanofi Pasteur Inc.
    • 12.2.15. Serum Institute of India Pvt. Ltd.
    • 12.2.16. Shenzhen Kangtai Biological Products Co., Ltd.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us